"Clin Exp Vaccine Res"[ Journal] - Search Results

Year	Number of Results
2012	11
2013	37
2014	29
2015	26
2016	24
2017	21
2018	18
2019	18
2020	24
2021	40
2022	39
2023	41
2024	38

1

Safety, tolerability, and immunogenicity of PIKA-adjuvanted recombinant SARS-CoV-2 spike protein subunit vaccine in healthy adults: an open-label randomized phase I clinical trial.

Lim RJ, Qiu X, Leong RN, Gutierrez JL, Halima A, Mostafa M, Ghoneim Y, Abdrabo M, Rashad M, Hannawi S, Liu Y, Mojares Z. Lim RJ, et al. Clin Exp Vaccine Res. 2024 Oct;13(4):315-328. doi: 10.7774/cevr.2024.13.4.315. Epub 2024 Oct 31. Clin Exp Vaccine Res. 2024. PMID: 39525677 Free PMC article.

2

Anti-severe acute respiratory syndrome coronavirus 2 spike receptor-binding domain antibody levels in patients with systemic lupus erythematosus based on vaccination status and related factors in Indonesia.

Hamijoyo L, Philo P, Nathan DS, Tiara MR, Mardiana SR, Susandi E, Ghassani NG, Alisjahbana B. Hamijoyo L, et al. Clin Exp Vaccine Res. 2024 Oct;13(4):348-358. doi: 10.7774/cevr.2024.13.4.348. Epub 2024 Oct 31. Clin Exp Vaccine Res. 2024. PMID: 39525676 Free PMC article.

3

Clinical presentation, associated factors, and course of cutaneous reaction after the booster dose of COVID-19 vaccination.

Jirawattanadon P, Leeyaphan C, Koomanachai P, Pudchakan P, Bunyaratavej S, Kulthanan K, Tuchinda P, Hutachoke T, Nanchaipruek Y, Phumariyapong P. Jirawattanadon P, et al. Clin Exp Vaccine Res. 2024 Oct;13(4):309-314. doi: 10.7774/cevr.2024.13.4.309. Epub 2024 Oct 31. Clin Exp Vaccine Res. 2024. PMID: 39525675 Free PMC article.

4

COVID-19 vaccine hesitancy among medical students, health professionals, and health care workers: an umbrella review.

Iqbal S, Qudah T, Ali I, Abid J, Ahmad AMR. Iqbal S, et al. Clin Exp Vaccine Res. 2024 Oct;13(4):263-270. doi: 10.7774/cevr.2024.13.4.263. Epub 2024 Oct 31. Clin Exp Vaccine Res. 2024. PMID: 39525674 Free PMC article. Review.

5

Protective effects of immunization with a novel 4 recombinant pore-forming toxoid combination vaccine in a rabbit model of systemic methicillin-resistant Staphylococcus aureus infection.

Söderhäll T, Kim SB, Choi GS, Kang KR, Ji JH, Lee BL, Kang JH. Söderhäll T, et al. Clin Exp Vaccine Res. 2024 Oct;13(4):338-347. doi: 10.7774/cevr.2024.13.4.338. Epub 2024 Oct 31. Clin Exp Vaccine Res. 2024. PMID: 39525673 Free PMC article.

6

Safety and immunogenicity of PIKA-adjuvanted recombinant SARS-CoV-2 spike protein subunit vaccine as a booster against SARS-CoV-2: a phase II, open-label, randomized, double-blinded study.

Lim RJ, Qiu X, Alberto E, Capeding MR, Carlos J, Leong RN, Gutierrez JL, Trillana M, Liu Y, Mojares Z. Lim RJ, et al. Clin Exp Vaccine Res. 2024 Oct;13(4):329-337. doi: 10.7774/cevr.2024.13.4.329. Epub 2024 Oct 31. Clin Exp Vaccine Res. 2024. PMID: 39525672 Free PMC article.

7

Letter to the editor: Evaluating ChatGPT as a tool for educating caregivers on malaria vaccination for children.

Prazeres F. Prazeres F. Clin Exp Vaccine Res. 2024 Oct;13(4):370-371. doi: 10.7774/cevr.2024.13.4.370. Epub 2024 Oct 31. Clin Exp Vaccine Res. 2024. PMID: 39525671 Free PMC article. No abstract available.

8

How does geographical diversity shape vaccine efficacy?

Abavisani M, Ansari B, Ebadpour N, Sahebkar A. Abavisani M, et al. Clin Exp Vaccine Res. 2024 Oct;13(4):271-300. doi: 10.7774/cevr.2024.13.4.271. Epub 2024 Oct 31. Clin Exp Vaccine Res. 2024. PMID: 39525670 Free PMC article. Review.

9

Effect of SpikoGen subunit vaccine administration during pregnancy on fetal development of rats.

Aghsami M, Aljoiber H, Mirfendereski S, Mottaghi-Dastjerdi N, Soltani J, Aslani H, Shariatpanahi M. Aghsami M, et al. Clin Exp Vaccine Res. 2024 Oct;13(4):301-308. doi: 10.7774/cevr.2024.13.4.301. Epub 2024 Oct 31. Clin Exp Vaccine Res. 2024. PMID: 39525669 Free PMC article.

10

Completing the pieces of a puzzle: in-depth probing of Toxoplasma gondii rhoptry protein 4 as a promising target for vaccination using an in-silico approach.

Foroutan M, Shadravan MM. Foroutan M, et al. Clin Exp Vaccine Res. 2024 Oct;13(4):359-369. doi: 10.7774/cevr.2024.13.4.359. Epub 2024 Oct 31. Clin Exp Vaccine Res. 2024. PMID: 39525668 Free PMC article.

11

Incidence of narcolepsy symptoms after taking COVID-19 vaccines: a Jordanian cross-sectional study.

Al Katatbeh M, Al-Mashakbeh Y, Freihat H, Gharam H, Mohammad R, Aldalki R, Eid S, Sharman R, Heissat N, Al-Samarraie G, Al-Shaibie A, Khasawneh L. Al Katatbeh M, et al. Clin Exp Vaccine Res. 2024 Jul;13(3):218-224. doi: 10.7774/cevr.2024.13.3.218. Epub 2024 Jul 31. Clin Exp Vaccine Res. 2024. PMID: 39144130 Free PMC article.

12

Immunogenicity of a novel inactivated canine adenovirus type 2 variant vaccine for dogs.

Yang DK, Ahn S, Lee HJ, Kim M, Kim JT, Lee JY, Cho YS. Yang DK, et al. Clin Exp Vaccine Res. 2024 Jul;13(3):253-258. doi: 10.7774/cevr.2024.13.3.253. Epub 2024 Jul 31. Clin Exp Vaccine Res. 2024. PMID: 39144129 Free PMC article.

13

The BCG vaccine, advantages, and disadvantages of introducing new generation vaccines against Mycobacterium tuberculosis.

Ari MM, Beig M, Sholeh M, Khoshmirsafa M. Ari MM, et al. Clin Exp Vaccine Res. 2024 Jul;13(3):184-201. doi: 10.7774/cevr.2024.13.3.184. Epub 2024 Jul 31. Clin Exp Vaccine Res. 2024. PMID: 39144128 Free PMC article. Review.

14

Insights into structural vaccinology harnessed for universal coronavirus vaccine development.

Lim CP, Leow CH, Lim HT, Kok BH, Chuah C, Oliveira JIN, Jones M, Leow CY. Lim CP, et al. Clin Exp Vaccine Res. 2024 Jul;13(3):202-217. doi: 10.7774/cevr.2024.13.3.202. Epub 2024 Jul 31. Clin Exp Vaccine Res. 2024. PMID: 39144127 Free PMC article. Review.

15

SARS-CoV-2 parental vaccination and risk of multisystem inflammatory syndrome in children: a single-center retrospective study.

Falsaperla R, Sortino V, Collotta AD, Grassi P, Vaccalluzzo MS, Pulvirenti A, Gambilonghi F, Ruggieri M. Falsaperla R, et al. Clin Exp Vaccine Res. 2024 Jul;13(3):225-231. doi: 10.7774/cevr.2024.13.3.225. Epub 2024 Jul 31. Clin Exp Vaccine Res. 2024. PMID: 39144126 Free PMC article.

16

The influence of Omicron on vaccine efficacy and durability: a neurology perspective.

Muruganantham JK, Veerabathiran R. Muruganantham JK, et al. Clin Exp Vaccine Res. 2024 Jul;13(3):175-183. doi: 10.7774/cevr.2024.13.3.175. Epub 2024 Jul 31. Clin Exp Vaccine Res. 2024. PMID: 39144125 Free PMC article. Review.

17

Urinary incontinence after COVID-19 vaccination: a case study in an 8-year-old boy.

Dao TL, Nguyen TK, Nguyen XB, Le KD, Duong KL, Bui DM, Nguyen Le CA, Hoang VT. Dao TL, et al. Clin Exp Vaccine Res. 2024 Jul;13(3):259-262. doi: 10.7774/cevr.2024.13.3.259. Epub 2024 Jul 31. Clin Exp Vaccine Res. 2024. PMID: 39144124 Free PMC article.

18

Intranasal and intraperitoneal immunization against Brucella infection using niosome and mannosylated niosomes containing Brucella recombinant trigger factor/Bp26/Omp31 chimeric protein in a mouse model.

Sharif F, Nazari R, Fasihi-Ramandi M, Taheri RA, Zargar M. Sharif F, et al. Clin Exp Vaccine Res. 2024 Jul;13(3):232-241. doi: 10.7774/cevr.2024.13.3.232. Epub 2024 Jul 31. Clin Exp Vaccine Res. 2024. PMID: 39144123 Free PMC article.

19

Development and validation of enzyme-linked immunosorbent assay for anti-mouse pertussis immunoglobulin G using international reference anti-Bordetella pertussis mouse serum NIBSC 97/642.

Kang KR, Kwon YH, Cho GW, Choi GS, Ji JH, Kang HM, Lee SY, Kang JH. Kang KR, et al. Clin Exp Vaccine Res. 2024 Jul;13(3):242-252. doi: 10.7774/cevr.2024.13.3.242. Epub 2024 Jul 31. Clin Exp Vaccine Res. 2024. PMID: 39144122 Free PMC article.

20

Henoch-Schönlein purpura following mRNA COVID-19 vaccination: a case report.

Lee MO, Yoo SJ. Lee MO, et al. Clin Exp Vaccine Res. 2024 Apr;13(2):166-170. doi: 10.7774/cevr.2024.13.2.166. Epub 2024 Apr 30. Clin Exp Vaccine Res. 2024. PMID: 38752010 Free PMC article.

21

A narrative review of genomic characteristics, serotype, immunogenicity, and vaccine development of Streptococcus pneumoniae capsular polysaccharide.

Sari RF, Fadilah F, Maladan Y, Sarassari R, Safari D. Sari RF, et al. Clin Exp Vaccine Res. 2024 Apr;13(2):91-104. doi: 10.7774/cevr.2024.13.2.91. Epub 2024 Apr 30. Clin Exp Vaccine Res. 2024. PMID: 38752009 Free PMC article. Review.

22

Inferring B-cell derived T-cell receptor induced multi-epitope-based vaccine candidate against enterovirus 71: a reverse vaccinology approach.

Swain SK, Panda S, Sahu BP, Mahapatra SR, Dey J, Sarangi R, Misra N. Swain SK, et al. Clin Exp Vaccine Res. 2024 Apr;13(2):132-145. doi: 10.7774/cevr.2024.13.2.132. Epub 2024 Apr 30. Clin Exp Vaccine Res. 2024. PMID: 38752008 Free PMC article.

23

A case of alopecia areata after rabies vaccination: unreported adverse effect?

Qiu G, Chen X. Qiu G, et al. Clin Exp Vaccine Res. 2024 Apr;13(2):171-173. doi: 10.7774/cevr.2024.13.2.171. Epub 2024 Apr 30. Clin Exp Vaccine Res. 2024. PMID: 38752007 Free PMC article.

24

Analysis of physical and biological delivery systems for DNA cancer vaccines and their translation to clinical development.

Oelkrug C. Oelkrug C. Clin Exp Vaccine Res. 2024 Apr;13(2):73-82. doi: 10.7774/cevr.2024.13.2.73. Epub 2024 Apr 30. Clin Exp Vaccine Res. 2024. PMID: 38752006 Free PMC article. Review.

25

Safety assessments of recombinant DTaP vaccines developed in South Korea.

Choi GS, Kang KR, Kim SB, Ji JH, Cho GW, Kang HM, Kang JH. Choi GS, et al. Clin Exp Vaccine Res. 2024 Apr;13(2):155-165. doi: 10.7774/cevr.2024.13.2.155. Epub 2024 Apr 30. Clin Exp Vaccine Res. 2024. PMID: 38752005 Free PMC article.

26

Vaccinomics and adversomics: key elements for a personalized vaccinology.

Laganà A, Visalli G, Di Pietro A, Facciolà A. Laganà A, et al. Clin Exp Vaccine Res. 2024 Apr;13(2):105-120. doi: 10.7774/cevr.2024.13.2.105. Epub 2024 Apr 30. Clin Exp Vaccine Res. 2024. PMID: 38752004 Free PMC article. Review.

27

Efficacy, immunogenicity, and safety of COVID-19 vaccines in individuals with liver cirrhosis: a rapid review and meta-analysis.

Salajegheh F, Rukerd MRZ, Nakhaie M, Ghoreshi ZA, Charostad J, Arefinia N. Salajegheh F, et al. Clin Exp Vaccine Res. 2024 Apr;13(2):83-90. doi: 10.7774/cevr.2024.13.2.83. Epub 2024 Apr 30. Clin Exp Vaccine Res. 2024. PMID: 38752003 Free PMC article. Review.

28

Immunoinformatics studies and design of a novel multi-epitope peptide vaccine against Toxoplasma gondii based on calcium-dependent protein kinases antigens through an in-silico analysis.

Ghaffari AD, Rahimi F. Ghaffari AD, et al. Clin Exp Vaccine Res. 2024 Apr;13(2):146-154. doi: 10.7774/cevr.2024.13.2.146. Epub 2024 Apr 30. Clin Exp Vaccine Res. 2024. PMID: 38752002 Free PMC article.

29

Evaluating the knowledge, attitude, perception, and readiness of caregivers of under 5-year-old children to accept malaria vaccine in Nigeria.

Emmanuel BN, Ishaq AN, Akunne OZ, Saidu UF. Emmanuel BN, et al. Clin Exp Vaccine Res. 2024 Apr;13(2):121-131. doi: 10.7774/cevr.2024.13.2.121. Epub 2024 Apr 30. Clin Exp Vaccine Res. 2024. PMID: 38752001 Free PMC article.

30

Monitoring and evaluation of provincial classical swine fever immunization implementation with an E2 subunit vaccine in Jeju Island, South Korea.

Jang G, Kim EJ, Cho SC, Moon SU, Lee MH, Ko JA, Ko SB, Lee J, Lee C. Jang G, et al. Clin Exp Vaccine Res. 2024 Jan;13(1):54-62. doi: 10.7774/cevr.2024.13.1.54. Epub 2024 Jan 31. Clin Exp Vaccine Res. 2024. PMID: 38362374 Free PMC article.

31

Current development of therapeutic vaccines for the treatment of chronic infectious diseases.

Park PG, Fatima M, An T, Moon YE, Woo S, Youn H, Hong KJ. Park PG, et al. Clin Exp Vaccine Res. 2024 Jan;13(1):21-27. doi: 10.7774/cevr.2024.13.1.21. Epub 2024 Jan 31. Clin Exp Vaccine Res. 2024. PMID: 38362373 Free PMC article. Review.

32

Effectiveness of BBV152 vaccine and ChAdOx1-S vaccine in preventing severe disease among vaccinated patients admitted to a designated COVID-19 hospital in India.

Nivetha R, Anshul R, Sarojini S, Sivagurunathan C, Maikandaan CJ. Nivetha R, et al. Clin Exp Vaccine Res. 2024 Jan;13(1):28-34. doi: 10.7774/cevr.2024.13.1.28. Epub 2024 Jan 31. Clin Exp Vaccine Res. 2024. PMID: 38362372 Free PMC article.

33

Humanized mouse model for vaccine evaluation: an overview.

Kaushik S, Kumari L, Deepak RK. Kaushik S, et al. Clin Exp Vaccine Res. 2024 Jan;13(1):10-20. doi: 10.7774/cevr.2024.13.1.10. Epub 2024 Jan 31. Clin Exp Vaccine Res. 2024. PMID: 38362371 Free PMC article. Review.

34

Acute interstitial nephritis with acute kidney injury after COVID-19 vaccination: a case report.

Lim J, Paek JH, Shin HC, Park WY, Jin K, Choe M, Han S, Kim Y. Lim J, et al. Clin Exp Vaccine Res. 2024 Jan;13(1):68-71. doi: 10.7774/cevr.2024.13.1.68. Epub 2024 Jan 31. Clin Exp Vaccine Res. 2024. PMID: 38362370 Free PMC article.

35

Comparative analysis of antibody responses to BNT162b2, ChAdOx1, and CoronaVac vaccines in the Albanian population over the pandemic years 2021 to 2022.

Sulcebe G, Kurti-Prifti M, Shyti E, Dashi-Pasholli J, Cenko F, Ylli A. Sulcebe G, et al. Clin Exp Vaccine Res. 2024 Jan;13(1):63-67. doi: 10.7774/cevr.2024.13.1.63. Epub 2024 Jan 31. Clin Exp Vaccine Res. 2024. PMID: 38362369 Free PMC article.

36

Acute abdomen following COVID-19 vaccination: a systematic review.

Cahuapaza-Gutierrez NL, Pajuelo-Vasquez R, Quiroz-Narvaez C, Rioja-Torres F, Quispe-Andahua M, Runzer-Colmenares FM. Cahuapaza-Gutierrez NL, et al. Clin Exp Vaccine Res. 2024 Jan;13(1):42-53. doi: 10.7774/cevr.2024.13.1.42. Epub 2024 Jan 31. Clin Exp Vaccine Res. 2024. PMID: 38362368 Free PMC article.

37

Immune modulation and possible pathological implications mediated by naturally produced immunoglobulin G idiotypes: from historical to recent experimental and clinical studies focused on atopic dermatitis.

Santander L, Machado NR, Fagundes BO, Victor JR. Santander L, et al. Clin Exp Vaccine Res. 2024 Jan;13(1):1-9. doi: 10.7774/cevr.2024.13.1.1. Epub 2024 Jan 31. Clin Exp Vaccine Res. 2024. PMID: 38362367 Free PMC article. Review.

38

Safety and immunogenicity of different booster vaccination schemes for COVID-19 used in El Salvador.

Sandoval X, Domínguez R, Recinos D, Zelaya S, Cativo P, Docena GH. Sandoval X, et al. Clin Exp Vaccine Res. 2024 Jan;13(1):35-41. doi: 10.7774/cevr.2024.13.1.35. Epub 2024 Jan 31. Clin Exp Vaccine Res. 2024. PMID: 38362366 Free PMC article.

39

Impact of COVID-19 pandemic on routine immunization services in a tertiary care hospital of Rajasthan, India.

Dhamania M, Gaur K. Dhamania M, et al. Clin Exp Vaccine Res. 2023 Oct;12(4):313-318. doi: 10.7774/cevr.2023.12.4.313. Epub 2023 Oct 31. Clin Exp Vaccine Res. 2023. PMID: 38025919 Free PMC article.

40

Impact of the COVID-19 vaccine booster strategy on vaccine protection: a pilot study of a military hospital in Taiwan.

Wang YL, Cheng ST, Shen CF, Huang SW, Cheng CM. Wang YL, et al. Clin Exp Vaccine Res. 2023 Oct;12(4):337-345. doi: 10.7774/cevr.2023.12.4.337. Epub 2023 Oct 31. Clin Exp Vaccine Res. 2023. PMID: 38025918 Free PMC article.

41

Lassa fever vaccine prospects: identifying immunodominant multi-epitopes as vaccine candidate.

Nwabueze CO. Nwabueze CO. Clin Exp Vaccine Res. 2023 Oct;12(4):346-347. doi: 10.7774/cevr.2023.12.4.346. Epub 2023 Oct 31. Clin Exp Vaccine Res. 2023. PMID: 38025917 Free PMC article. No abstract available.

42

Comparison of media for a human peripheral blood mononuclear cell-based in vitro vaccine evaluation system.

Gong S, Fajar P, De Vries-Idema J, Huckriede A. Gong S, et al. Clin Exp Vaccine Res. 2023 Oct;12(4):328-336. doi: 10.7774/cevr.2023.12.4.328. Epub 2023 Oct 31. Clin Exp Vaccine Res. 2023. PMID: 38025916 Free PMC article.

43

Serological response 5 months after the BNT162b2 COVID-19 vaccination in patients with various hematological disorders in Japan.

Marumo Y, Yoshida T, Furukawa Y, Ina K, Kamiya A, Kataoka T, Kayukawa S. Marumo Y, et al. Clin Exp Vaccine Res. 2023 Oct;12(4):319-327. doi: 10.7774/cevr.2023.12.4.319. Epub 2023 Oct 31. Clin Exp Vaccine Res. 2023. PMID: 38025915 Free PMC article.

44

COVID-19 vaccine-induced immune thrombotic thrombocytopenia: a review.

Suhaimi SNAA, Zaki IAH, Noordin ZM, Hussin NSM, Ming LC, Zulkifly HH. Suhaimi SNAA, et al. Clin Exp Vaccine Res. 2023 Oct;12(4):265-290. doi: 10.7774/cevr.2023.12.4.265. Epub 2023 Oct 31. Clin Exp Vaccine Res. 2023. PMID: 38025914 Free PMC article. Review.

45

Immunization of mice with chimeric protein-loaded aluminum hydroxide and selenium nanoparticles induces reduction of Brucella melitensis infection in mice.

Goudarzi T, Abkar M, Zamanzadeh Z, Fasihi-Ramandi M. Goudarzi T, et al. Clin Exp Vaccine Res. 2023 Oct;12(4):304-312. doi: 10.7774/cevr.2023.12.4.304. Epub 2023 Oct 31. Clin Exp Vaccine Res. 2023. PMID: 38025913 Free PMC article.

46

Barriers to measles mumps rubella vaccine acceptance in the three southern border provinces of Thailand.

Sirithammaphan U, Chaisang U, Pongrattanamarn K. Sirithammaphan U, et al. Clin Exp Vaccine Res. 2023 Oct;12(4):298-303. doi: 10.7774/cevr.2023.12.4.298. Epub 2023 Oct 31. Clin Exp Vaccine Res. 2023. PMID: 38025912 Free PMC article.

47

Experimental animal models for development of human enterovirus vaccine.

Song JM. Song JM. Clin Exp Vaccine Res. 2023 Oct;12(4):291-297. doi: 10.7774/cevr.2023.12.4.291. Epub 2023 Oct 31. Clin Exp Vaccine Res. 2023. PMID: 38025911 Free PMC article. Review.

48

Factors associated with parental intention to vaccinate their preschool children against COVID-19: a cross-sectional survey in urban area of Jakarta, Indonesia.

Santi T, Hegar B, Munasir Z, Prayitno A, Werdhani RA, Bandar INS, Jo J, Uswa R, Widia R, Vandenplas Y. Santi T, et al. Clin Exp Vaccine Res. 2023 Jul;12(3):240-248. doi: 10.7774/cevr.2023.12.3.240. Epub 2023 Jul 31. Clin Exp Vaccine Res. 2023. PMID: 37599811 Free PMC article.

49

Vaccine hesitancy: acceptance of COVID-19 vaccine in Pakistan.

Qazi SH, Masoud S, Usmani MA. Qazi SH, et al. Clin Exp Vaccine Res. 2023 Jul;12(3):209-215. doi: 10.7774/cevr.2023.12.3.209. Epub 2023 Jul 31. Clin Exp Vaccine Res. 2023. PMID: 37599810 Free PMC article.

50

Exploring the essential need for developing COVID-19 vaccines in the Philippines.

Cordero DA Jr. Cordero DA Jr. Clin Exp Vaccine Res. 2023 Jul;12(3):260-261. doi: 10.7774/cevr.2023.12.3.260. Epub 2023 Jul 31. Clin Exp Vaccine Res. 2023. PMID: 37599809 Free PMC article. No abstract available.

51

Is SARS-CoV-2 vaccination related Guillain-Barré syndrome really different from that due to other causes?

Finsterer J. Finsterer J. Clin Exp Vaccine Res. 2023 Jul;12(3):262-263. doi: 10.7774/cevr.2023.12.3.262. Epub 2023 Jul 31. Clin Exp Vaccine Res. 2023. PMID: 37599808 Free PMC article. No abstract available.

52

The issue of vaccine refusal: the study of a risky behavior.

Osadchuk M, Tikhonova Y, Krivetskaya M. Osadchuk M, et al. Clin Exp Vaccine Res. 2023 Jul;12(3):216-223. doi: 10.7774/cevr.2023.12.3.216. Epub 2023 Jul 31. Clin Exp Vaccine Res. 2023. PMID: 37599807 Free PMC article.

53

Antibody response to COVID-19 vaccination in patients on chronic hemodialysis.

Choi H, Han S, Kim JS, Park B, Lee MJ, Shin GT, Kim H, Kim K, Park AY, Shin HJ, Park I. Choi H, et al. Clin Exp Vaccine Res. 2023 Jul;12(3):249-259. doi: 10.7774/cevr.2023.12.3.249. Epub 2023 Jul 31. Clin Exp Vaccine Res. 2023. PMID: 37599806 Free PMC article.

54

Anti-SARS-CoV-2 receptor binding domain antibodies after the second dose of Sinovac and AstraZeneca vaccination.

Gondokesumo ME, Purnamayanti A, Hanum PS, Santosa WN, Wardhana AP, Avanti C. Gondokesumo ME, et al. Clin Exp Vaccine Res. 2023 Jul;12(3):224-231. doi: 10.7774/cevr.2023.12.3.224. Epub 2023 Jul 31. Clin Exp Vaccine Res. 2023. PMID: 37599805 Free PMC article.

55

Vaccines development in India: advances, regulation, and challenges.

Salalli R, Dange JR, Dhiman S, Sharma T. Salalli R, et al. Clin Exp Vaccine Res. 2023 Jul;12(3):193-208. doi: 10.7774/cevr.2023.12.3.193. Epub 2023 Jul 31. Clin Exp Vaccine Res. 2023. PMID: 37599804 Free PMC article. Review.

56

Perspective vaccines for emerging viral diseases in farm animals.

Allam AM, Elbayoumy MK, Ghazy AA. Allam AM, et al. Clin Exp Vaccine Res. 2023 Jul;12(3):179-192. doi: 10.7774/cevr.2023.12.3.179. Epub 2023 Jul 31. Clin Exp Vaccine Res. 2023. PMID: 37599803 Free PMC article. Review.

57

Immunogenic characterization of AlPO₄ adsorbed Td vaccine and liposome-mediated Td vaccine.

Shuhsadhe R, Vazhayil J, Ali HS, Orsud H, Mergani AEO. Shuhsadhe R, et al. Clin Exp Vaccine Res. 2023 Jul;12(3):232-239. doi: 10.7774/cevr.2023.12.3.232. Epub 2023 Jul 31. Clin Exp Vaccine Res. 2023. PMID: 37599802 Free PMC article.

58

Immunogenicity of the ChAdOx1 nCoV-19 vaccine in patients with hematologic malignancies.

Thookhamme C, Navinpipat M, Sasakul A, Pattarakosol P, Lertchaisataporn K, Tawinprai K, Praditsuktavorn P. Thookhamme C, et al. Clin Exp Vaccine Res. 2023 Apr;12(2):107-115. doi: 10.7774/cevr.2023.12.2.107. Epub 2023 Apr 30. Clin Exp Vaccine Res. 2023. PMID: 37214149 Free PMC article.

59

Detection of immunity in sheep following anti-rabies vaccination.

Rathnadiwakara H, Gunatilake M, Cliquet F, Wasniewski M, Thammitiyagodage M, Karunakaran R, Thibault JC, Ijas M. Rathnadiwakara H, et al. Clin Exp Vaccine Res. 2023 Apr;12(2):97-106. doi: 10.7774/cevr.2023.12.2.97. Epub 2023 Apr 30. Clin Exp Vaccine Res. 2023. PMID: 37214148 Free PMC article.

60

Nondaily dosing schedule of allergen-specific sublingual immunotherapy: efficacy and safety.

Abdelwahab HW, Abd El-Maksoud A. Abdelwahab HW, et al. Clin Exp Vaccine Res. 2023 Apr;12(2):121-126. doi: 10.7774/cevr.2023.12.2.121. Epub 2023 Apr 30. Clin Exp Vaccine Res. 2023. PMID: 37214147 Free PMC article.

61

Occurrence of erythema multiforme following COVID-19 vaccination: a review.

Yousefian M, Khadivi A. Yousefian M, et al. Clin Exp Vaccine Res. 2023 Apr;12(2):87-96. doi: 10.7774/cevr.2023.12.2.87. Epub 2023 Apr 30. Clin Exp Vaccine Res. 2023. PMID: 37214146 Free PMC article. Review.

62

Pregnant women's knowledge about and beliefs toward COVID-19 vaccine: a cross-sectional study.

Gunkaya OS, Tekin AB, Yassa M, Arslan O, Karakoç K, Demirtaş N, Usta C, Künt İşgüder Ç, Tuğ N. Gunkaya OS, et al. Clin Exp Vaccine Res. 2023 Apr;12(2):134-142. doi: 10.7774/cevr.2023.12.2.134. Epub 2023 Apr 30. Clin Exp Vaccine Res. 2023. PMID: 37214145 Free PMC article.

63

Changes in SARS-CoV-2 antibody titers 6 months after the booster dose of BNT162b2 COVID-19 vaccine among health care workers.

Mochizuki T, Hori T, Yano K, Ikari K, Okazaki K. Mochizuki T, et al. Clin Exp Vaccine Res. 2023 Apr;12(2):116-120. doi: 10.7774/cevr.2023.12.2.116. Epub 2023 Apr 30. Clin Exp Vaccine Res. 2023. PMID: 37214144 Free PMC article.

64

Strategic construction of mRNA vaccine derived from conserved and experimentally validated epitopes of avian influenza type A virus: a reverse vaccinology approach.

Herrera-Ong LR. Herrera-Ong LR. Clin Exp Vaccine Res. 2023 Apr;12(2):156-171. doi: 10.7774/cevr.2023.12.2.156. Epub 2023 Apr 30. Clin Exp Vaccine Res. 2023. PMID: 37214143 Free PMC article.

65

Exploring the underlying factors of COVID-19 vaccination hesitancy in Ahvaz, Iran: a comprehensive cross-sectional study.

Afshari P, Alavi SM, Abedi P, Beheshtinasab M, Dashtpayma S, Amiri H. Afshari P, et al. Clin Exp Vaccine Res. 2023 Apr;12(2):127-133. doi: 10.7774/cevr.2023.12.2.127. Epub 2023 Apr 30. Clin Exp Vaccine Res. 2023. PMID: 37214142 Free PMC article.

66

Disseminated life-threatening viral skin rash in a child with atopic dermatitis.

Herzum A, Occella C, Garibeh E, Gariazzo L, Viglizzo G. Herzum A, et al. Clin Exp Vaccine Res. 2023 Apr;12(2):176-178. doi: 10.7774/cevr.2023.12.2.176. Epub 2023 Apr 30. Clin Exp Vaccine Res. 2023. PMID: 37214141 Free PMC article.

67

Guillain-Barré syndrome associated with SARS-CoV-2 vaccination: how is it different? a systematic review and individual participant data meta-analysis.

Reddy YM, Murthy JM, Osman S, Jaiswal SK, Gattu AK, Pidaparthi L, Boorgu SK, Chavan R, Ramakrishnan B, Yeduguri SR. Reddy YM, et al. Clin Exp Vaccine Res. 2023 Apr;12(2):143-155. doi: 10.7774/cevr.2023.12.2.143. Epub 2023 Apr 30. Clin Exp Vaccine Res. 2023. PMID: 37214140 Free PMC article.

68

A case report overlapped vaccine and COVID-19 in disseminated atherosclerosis.

Bayrak V. Bayrak V. Clin Exp Vaccine Res. 2023 Apr;12(2):172-175. doi: 10.7774/cevr.2023.12.2.172. Epub 2023 Apr 30. Clin Exp Vaccine Res. 2023. PMID: 37214139 Free PMC article.

69

Individual expression and processing of hepatitis C virus E1/E2 epitopes-based DNA vaccine candidate in healthy humans' peripheral blood mononuclear cells.

Nadeem R, Maghraby AS, Abd-Elshafy DN, Barakat AB, Bahgat MM. Nadeem R, et al. Clin Exp Vaccine Res. 2023 Jan;12(1):47-59. doi: 10.7774/cevr.2023.12.1.47. Epub 2023 Jan 31. Clin Exp Vaccine Res. 2023. PMID: 36844691 Free PMC article.

70

Comparative evaluation of gold nanoparticles and Alum as immune enhancers against rabies vaccine and related immune reactivity, physiological, and histopathological alterations: in vivo study.

El-Hennamy REE, Mahmoud SM, El-Yamany NA, Hassanein HH, Amer ME, Mohamed AF. El-Hennamy REE, et al. Clin Exp Vaccine Res. 2023 Jan;12(1):32-46. doi: 10.7774/cevr.2023.12.1.32. Epub 2023 Jan 31. Clin Exp Vaccine Res. 2023. PMID: 36844690 Free PMC article.

71

Herpes zoster ophthalmicus after COVID-19 vaccine booster in healthy younger adult: a case report.

Awaly ZWN. Awaly ZWN. Clin Exp Vaccine Res. 2023 Jan;12(1):82-84. doi: 10.7774/cevr.2023.12.1.82. Epub 2023 Jan 31. Clin Exp Vaccine Res. 2023. PMID: 36844689 Free PMC article.

72

Adverse events following immunisation with the first dose of sputnik V among Iranian health care providers.

Jafarzadeh Esfehani R, Zahmatkesh M, Goldozian R, Farkhonde J, Jaripour E, Hatami A, Bidkhori HR, Shamsian SK, Shamsian SA, Mojahedi F. Jafarzadeh Esfehani R, et al. Clin Exp Vaccine Res. 2023 Jan;12(1):25-31. doi: 10.7774/cevr.2023.12.1.25. Epub 2023 Jan 31. Clin Exp Vaccine Res. 2023. PMID: 36844688 Free PMC article.

73

Exploring the experience of developing COVID-19 vaccines in Iran.

Ghanei M, Mohabattalab A, Fartash K, Kolahchi N, Khakdaman A, Kaghazian H, Bagheri A. Ghanei M, et al. Clin Exp Vaccine Res. 2023 Jan;12(1):1-12. doi: 10.7774/cevr.2023.12.1.1. Epub 2023 Jan 31. Clin Exp Vaccine Res. 2023. PMID: 36844687 Free PMC article. Review.

74

Before blaming SARS-CoV-2 vaccines for thalamic lacunar stroke, alternative etiologies must be ruled out.

Finsterer J. Finsterer J. Clin Exp Vaccine Res. 2023 Jan;12(1):85-86. doi: 10.7774/cevr.2023.12.1.85. Epub 2023 Jan 31. Clin Exp Vaccine Res. 2023. PMID: 36844686 Free PMC article. No abstract available.

75

Humoral immune response to SARS-CoV-2 mRNA vaccines is associated with choice of vaccine and systemic adverse reactions.

Klingel H, Krüttgen A, Imöhl M, Kleines M. Klingel H, et al. Clin Exp Vaccine Res. 2023 Jan;12(1):60-69. doi: 10.7774/cevr.2023.12.1.60. Epub 2023 Jan 31. Clin Exp Vaccine Res. 2023. PMID: 36844685 Free PMC article.

76

New typhoid vaccine using sponge-like reduced protocol: development and evaluation.

Bahy R, Gaber A, Zedan H, Mabrook M. Bahy R, et al. Clin Exp Vaccine Res. 2023 Jan;12(1):70-76. doi: 10.7774/cevr.2023.12.1.70. Epub 2023 Jan 31. Clin Exp Vaccine Res. 2023. PMID: 36844684 Free PMC article.

77

The threat of Monkeypox in the Philippines: another problematic preparation and management for the healthcare system?

Cordero DA Jr. Cordero DA Jr. Clin Exp Vaccine Res. 2023 Jan;12(1):77-79. doi: 10.7774/cevr.2023.12.1.77. Epub 2023 Jan 31. Clin Exp Vaccine Res. 2023. PMID: 36844683 Free PMC article.

78

Seroconversion rates in kidney transplant recipients following SARS-CoV-2 vaccination and its association with immunosuppressive agents: a systematic review and meta-analysis.

Iryaningrum MR, Cahyadi A, Damara FA, Bandiara R, Marbun MBH. Iryaningrum MR, et al. Clin Exp Vaccine Res. 2023 Jan;12(1):13-24. doi: 10.7774/cevr.2023.12.1.13. Epub 2023 Jan 31. Clin Exp Vaccine Res. 2023. PMID: 36844682 Free PMC article. Review.

79

Psoriasis flares after COVID-19 vaccination: adherence to biologic therapy reduces psoriasis exacerbations: a case-control study.

Burlando M, Herzum A, Cozzani E, Parodi A. Burlando M, et al. Clin Exp Vaccine Res. 2023 Jan;12(1):80-81. doi: 10.7774/cevr.2023.12.1.80. Epub 2023 Jan 31. Clin Exp Vaccine Res. 2023. PMID: 36844681 Free PMC article.

80

Deep vein thrombosis and acute hepatitis after ChAdOx1 nCov-19 vaccination in a Charcot-Marie-Tooth patient: a case report.

Napoli R, Visonà E. Napoli R, et al. Clin Exp Vaccine Res. 2022 Sep;11(3):294-297. doi: 10.7774/cevr.2022.11.3.294. Epub 2022 Sep 30. Clin Exp Vaccine Res. 2022. PMID: 36451672 Free PMC article.

81

Livedo reticularis following administration of ChAdOx1 nCoV-19 vaccine (AZD1222): a report of two cases.

Kim JH, Uh JA, Kim HS, Lee SK, Kim MS, Lee UH. Kim JH, et al. Clin Exp Vaccine Res. 2022 Sep;11(3):298-301. doi: 10.7774/cevr.2022.11.3.298. Epub 2022 Sep 30. Clin Exp Vaccine Res. 2022. PMID: 36451671 Free PMC article.

82

Identifying immunodominant multi-epitopes from the envelope glycoprotein of the Lassa mammarenavirus as vaccine candidate for Lassa fever.

Rowaiye AB, Nwonu EJ, Asala TM, Ogu AC, Bur D, Chukwu C, Oli AN, Agbalalah T. Rowaiye AB, et al. Clin Exp Vaccine Res. 2022 Sep;11(3):249-263. doi: 10.7774/cevr.2022.11.3.249. Epub 2022 Sep 30. Clin Exp Vaccine Res. 2022. PMID: 36451670 Free PMC article.

83

Factors associated with intention to take COVID-19 vaccine among the university students in Bangladesh.

Shuvo NA, Mondal MSH. Shuvo NA, et al. Clin Exp Vaccine Res. 2022 Sep;11(3):274-284. doi: 10.7774/cevr.2022.11.3.274. Epub 2022 Sep 30. Clin Exp Vaccine Res. 2022. PMID: 36451669 Free PMC article.

84

Development of mucosal vaccine delivery: an overview on the mucosal vaccines and their adjuvants.

Anggraeni R, Ana ID, Wihadmadyatami H. Anggraeni R, et al. Clin Exp Vaccine Res. 2022 Sep;11(3):235-248. doi: 10.7774/cevr.2022.11.3.235. Epub 2022 Sep 30. Clin Exp Vaccine Res. 2022. PMID: 36451668 Free PMC article. Review.

85

Field evaluation of the safety and immunogenicity of a classical swine fever virus E2 subunit vaccine in breeding and nursery animals on Jeju Island, South Korea.

Jang G, Kim EJ, Cho SC, Moon SU, Kim BS, Kim J, Jeong KJ, Song K, Mun SH, Kang WM, Lee J, Park C, Yang HS, Lee C. Jang G, et al. Clin Exp Vaccine Res. 2022 Sep;11(3):264-273. doi: 10.7774/cevr.2022.11.3.264. Epub 2022 Sep 30. Clin Exp Vaccine Res. 2022. PMID: 36451667 Free PMC article.

86

COVID-19 vaccines development in Africa: a review of current situation and existing challenges of vaccine production.

Adeyemi O. Adeyemi O. Clin Exp Vaccine Res. 2022 Sep;11(3):302-303. doi: 10.7774/cevr.2022.11.3.302. Epub 2022 Sep 30. Clin Exp Vaccine Res. 2022. PMID: 36451666 Free PMC article. No abstract available.

87

Quick drop of platelet counts in children with chronic immune thrombocytopenia after COVID-19 mRNA vaccination: case reports.

Lassandro G, Carriero F, Palladino V, Del Vecchio GC, Giordano P. Lassandro G, et al. Clin Exp Vaccine Res. 2022 Sep;11(3):290-293. doi: 10.7774/cevr.2022.11.3.290. Epub 2022 Sep 30. Clin Exp Vaccine Res. 2022. PMID: 36451665 Free PMC article.

88

Recombinant proteins of spike protein of SARS-CoV-2 with the Omicron receptor-binding domain induce production of highly Omicron-specific neutralizing antibodies.

Kang H, Kim D, Min K, Park M, Kim SH, Sohn EJ, Choi BH, Hwang I. Kang H, et al. Clin Exp Vaccine Res. 2022 Sep;11(3):285-289. doi: 10.7774/cevr.2022.11.3.285. Epub 2022 Sep 30. Clin Exp Vaccine Res. 2022. PMID: 36451664 Free PMC article.

89

Unmasking the COVID-19 vaccination myths: intervention through collaboration.

Cordero DA Jr. Cordero DA Jr. Clin Exp Vaccine Res. 2022 Sep;11(3):304-305. doi: 10.7774/cevr.2022.11.3.304. Epub 2022 Sep 30. Clin Exp Vaccine Res. 2022. PMID: 36451663 Free PMC article. No abstract available.

90

Exploring the myths surrounding the COVID-19 vaccines in Africa: the study to investigate their impacts on acceptance using online survey and social media.

Lamptey E, Senkyire EK, Dorcas S, Benita DA, Boakye EO, Ikome T, Asamoah A. Lamptey E, et al. Clin Exp Vaccine Res. 2022 May;11(2):193-208. doi: 10.7774/cevr.2022.11.2.193. Epub 2022 May 31. Clin Exp Vaccine Res. 2022. PMID: 35799880 Free PMC article.

91

Evaluation of precipitation time of the aluminum salts adsorbed potentially frozen vaccines used in the Polish National Immunization Schedule for their pre-qualification before the administration.

Górska P, Główka M, Woźnica K, Zasada AA. Górska P, et al. Clin Exp Vaccine Res. 2022 May;11(2):155-162. doi: 10.7774/cevr.2022.11.2.155. Epub 2022 May 31. Clin Exp Vaccine Res. 2022. PMID: 35799879 Free PMC article.

92

COVID-19 vaccination policies and the new challenges of international travel.

Ramírez C, Choi JN, Durón RM. Ramírez C, et al. Clin Exp Vaccine Res. 2022 May;11(2):230-232. doi: 10.7774/cevr.2022.11.2.230. Epub 2022 May 31. Clin Exp Vaccine Res. 2022. PMID: 35799878 Free PMC article. No abstract available.

93

Thalamic hemi-chorea: a rare complication after receiving the adenoviral vector-based COVID-19 vaccine: a case report.

Shahali H, Farahani RH, Asgari A, Hazrati E. Shahali H, et al. Clin Exp Vaccine Res. 2022 May;11(2):217-221. doi: 10.7774/cevr.2022.11.2.217. Epub 2022 May 31. Clin Exp Vaccine Res. 2022. PMID: 35799877 Free PMC article.

94

SARS-CoV-2 vaccine challenge based on spike glycoprotein against several new variants.

Syahniar R, Kharisma DS. Syahniar R, et al. Clin Exp Vaccine Res. 2022 May;11(2):173-183. doi: 10.7774/cevr.2022.11.2.173. Epub 2022 May 31. Clin Exp Vaccine Res. 2022. PMID: 35799876 Free PMC article. Review.

95

Adult vaccine-related knowledge, attitudes, and behaviors in Turkey.

Karaoğlu SA, Taş BG, Toprak D. Karaoğlu SA, et al. Clin Exp Vaccine Res. 2022 May;11(2):133-140. doi: 10.7774/cevr.2022.11.2.133. Epub 2022 May 31. Clin Exp Vaccine Res. 2022. PMID: 35799875 Free PMC article.

96

Exploring interventions against COVID-19 vaccine hesitancy in the Philippines.

Cordero DA Jr. Cordero DA Jr. Clin Exp Vaccine Res. 2022 May;11(2):233-234. doi: 10.7774/cevr.2022.11.2.233. Epub 2022 May 31. Clin Exp Vaccine Res. 2022. PMID: 35799874 Free PMC article. No abstract available.

97

A survey of healthcare workers' recommendations about human papillomavirus vaccination.

Nishioka H, Onishi T, Kitano T, Takeyama M, Imakita N, Kasahara K, Kawaguchi R, Masaki JA, Nogami K. Nishioka H, et al. Clin Exp Vaccine Res. 2022 May;11(2):149-154. doi: 10.7774/cevr.2022.11.2.149. Epub 2022 May 31. Clin Exp Vaccine Res. 2022. PMID: 35799873 Free PMC article.

98

Subacute thyroiditis after receiving the vaccine for COVID-19: a case report and literature review.

Vu TB, Chu DT, Le DT, Hoang TTD, Gautret P, Hoang VT. Vu TB, et al. Clin Exp Vaccine Res. 2022 May;11(2):226-229. doi: 10.7774/cevr.2022.11.2.226. Epub 2022 May 31. Clin Exp Vaccine Res. 2022. PMID: 35799872 Free PMC article.

99

Epstein-Barr virus reactivation after COVID-19 vaccination in a young immunocompetent man: a case report.

Herzum A, Trave I, D'Agostino F, Burlando M, Cozzani E, Parodi A. Herzum A, et al. Clin Exp Vaccine Res. 2022 May;11(2):222-225. doi: 10.7774/cevr.2022.11.2.222. Epub 2022 May 31. Clin Exp Vaccine Res. 2022. PMID: 35799871 Free PMC article.

100

Heterologous prime-boost with the mRNA-1273 vaccine among CoronaVac-vaccinated healthcare workers in Indonesia.

Santi T, Sungono V, Kamarga L, Samakto B, Hidayat F, Hidayat FK, Satolom M, Permana A, Yusuf I, Suriapranata IM, Jo J. Santi T, et al. Clin Exp Vaccine Res. 2022 May;11(2):209-216. doi: 10.7774/cevr.2022.11.2.209. Epub 2022 May 31. Clin Exp Vaccine Res. 2022. PMID: 35799870 Free PMC article.

101

Nasal vaccine as a booster shot: a viable solution to restrict pandemic?

Meenakshi S, Kumar VU, Dhingra S, Murti K. Meenakshi S, et al. Clin Exp Vaccine Res. 2022 May;11(2):184-192. doi: 10.7774/cevr.2022.11.2.184. Epub 2022 May 31. Clin Exp Vaccine Res. 2022. PMID: 35799869 Free PMC article. Review.

102

Formulation of an ovarian cancer vaccine with the squalene-based AddaVax adjuvant inhibits the growth of murine epithelial ovarian carcinomas.

Mazumder S, Swank V, Dvorina N, Johnson JM, Tuohy VK. Mazumder S, et al. Clin Exp Vaccine Res. 2022 May;11(2):163-172. doi: 10.7774/cevr.2022.11.2.163. Epub 2022 May 31. Clin Exp Vaccine Res. 2022. PMID: 35799868 Free PMC article.

103

Possible different genotypes for human papillomavirus vaccination in lower middle-income countries towards cervical cancer elimination in 2030: a cross-sectional study.

Utami TW, Andrijono A, Putra A, Indarti J, Fleuren G, Jordanova E, Humairah I, Utomo A. Utami TW, et al. Clin Exp Vaccine Res. 2022 May;11(2):141-148. doi: 10.7774/cevr.2022.11.2.141. Epub 2022 May 31. Clin Exp Vaccine Res. 2022. PMID: 35799867 Free PMC article.

104

Alopecia areata after COVID-19 vaccination.

Gallo G, Mastorino L, Tonella L, Ribero S, Quaglino P. Gallo G, et al. Clin Exp Vaccine Res. 2022 Jan;11(1):129-132. doi: 10.7774/cevr.2022.11.1.129. Epub 2022 Jan 31. Clin Exp Vaccine Res. 2022. PMID: 35223675 Free PMC article.

105

The risk of confusion between AstraZeneka COVID-19 vaccine side effects and signs of COVID-19 infection: a case report.

Nomali M, Afzali M. Nomali M, et al. Clin Exp Vaccine Res. 2022 Jan;11(1):125-128. doi: 10.7774/cevr.2022.11.1.125. Epub 2022 Jan 31. Clin Exp Vaccine Res. 2022. PMID: 35223674 Free PMC article.

106

Severity of adverse reactions is associated with T-cell response in mRNA-1273 vaccinated health care workers.

Klingel H, Lauen M, Krüttgen A, Imöhl M, Kleines M. Klingel H, et al. Clin Exp Vaccine Res. 2022 Jan;11(1):121-124. doi: 10.7774/cevr.2022.11.1.121. Epub 2022 Jan 31. Clin Exp Vaccine Res. 2022. PMID: 35223673 Free PMC article.

107

Assessment on anti-SARS-CoV-2 receptor-binding domain antibodies among CoronaVac-vaccinated Indonesian adults.

Jo J, Sanjaya A, Pinontoan R, Aruan M, Wahyuni RM, Viktaria V. Jo J, et al. Clin Exp Vaccine Res. 2022 Jan;11(1):116-120. doi: 10.7774/cevr.2022.11.1.116. Epub 2022 Jan 31. Clin Exp Vaccine Res. 2022. PMID: 35223672 Free PMC article.

108

Reactogenicity to COVID-19 vaccination in the United States of America.

Sanyaolu A, Marinkovic A, Prakash S, Desai P, Haider N, Abbasi AF, Mehraban N, Jain I, Ekeh A, Shazley O, Okorie C, Orish VN. Sanyaolu A, et al. Clin Exp Vaccine Res. 2022 Jan;11(1):104-115. doi: 10.7774/cevr.2022.11.1.104. Epub 2022 Jan 31. Clin Exp Vaccine Res. 2022. PMID: 35223671 Free PMC article.

109

Large inter-individual variability of cellular and humoral immunological responses to mRNA-1273 (Moderna) vaccination against SARS-CoV-2 in health care workers.

Krüttgen A, Haase G, Haefner H, Imöhl M, Kleines M. Krüttgen A, et al. Clin Exp Vaccine Res. 2022 Jan;11(1):96-103. doi: 10.7774/cevr.2022.11.1.96. Epub 2022 Jan 31. Clin Exp Vaccine Res. 2022. PMID: 35223670 Free PMC article.

110

Factors associated with side effects of COVID-19 vaccine in Indonesia.

Wibowo J, Heriyanto RS, Wijovi F, Halim DA, Claudia C, Marcella E, Susanto B, Indrawan M, Heryadi NK, Imanuelly M, Anurantha JJ, Hariyanto TI, Marcellin C, Sinaga TD, Rizki SA, Sieto N, Siregar JI, Lugito NPH, Kurniawan A. Wibowo J, et al. Clin Exp Vaccine Res. 2022 Jan;11(1):89-95. doi: 10.7774/cevr.2022.11.1.89. Epub 2022 Jan 31. Clin Exp Vaccine Res. 2022. PMID: 35223669 Free PMC article.

111

COVID-19 vaccines development in Africa: a review of current situation and existing challenges of vaccine production.

Lamptey E, Senkyire EK, Benita DA, Boakye EO. Lamptey E, et al. Clin Exp Vaccine Res. 2022 Jan;11(1):82-88. doi: 10.7774/cevr.2022.11.1.82. Epub 2022 Jan 31. Clin Exp Vaccine Res. 2022. PMID: 35223668 Free PMC article. Review.

112

Successful seroconversion against diphtheria and tetanus induced through maternal vaccination in a region of Colombia.

Hincapie-Palacio D, Echeverri A, Hoyos C, Vargas-Restrepo F, Ospina M, Buitrago S, Ochoa J. Hincapie-Palacio D, et al. Clin Exp Vaccine Res. 2022 Jan;11(1):72-81. doi: 10.7774/cevr.2022.11.1.72. Epub 2022 Jan 31. Clin Exp Vaccine Res. 2022. PMID: 35223667 Free PMC article.

113

Knowledge, attitude, and practices regarding human papillomavirus and its' vaccination among the young medical professionals and students of Bangladesh.

Chowdhury S, Ara R, Roy S, Tanvir SMS, Eva FN, Neela TM, Moonmoon AA, Sifat S, Zamila M, Hawlader MDH. Chowdhury S, et al. Clin Exp Vaccine Res. 2022 Jan;11(1):63-71. doi: 10.7774/cevr.2022.11.1.63. Epub 2022 Jan 31. Clin Exp Vaccine Res. 2022. PMID: 35223666 Free PMC article.

114

Protection against virulent Brucella spp. by gamma-irradiated B. ovis in BALB/c mice model.

Al-Mariri A, Al-Hallab L, Alabras R, Kherbik H, Khawajkiah M. Al-Mariri A, et al. Clin Exp Vaccine Res. 2022 Jan;11(1):53-62. doi: 10.7774/cevr.2022.11.1.53. Epub 2022 Jan 31. Clin Exp Vaccine Res. 2022. PMID: 35223665 Free PMC article.

115

Protectivity and safety following recombinant hepatitis B vaccine with different source of bulk compared to hepatitis B (Bio Farma) vaccine in Indonesia.

Nency YM, Rahmadi FA, Mulyono, Anantyo DT, Farhanah N, Hapsari R, Farida H, Sadhana U, Djagat H, Kristina TN, Juniarto AZ, Puspita M, Sari RM, Bachtiar NS. Nency YM, et al. Clin Exp Vaccine Res. 2022 Jan;11(1):43-52. doi: 10.7774/cevr.2022.11.1.43. Epub 2022 Jan 31. Clin Exp Vaccine Res. 2022. PMID: 35223664 Free PMC article.

116

Preparation and field study of combined vaccine against Clostridium perfringens type A and bovine viral diarrhea virus in camels.

Elhelw HA, El Fadeel MRA, El-Sergany E, Allam A, Elbayoumy MK, El-Kattan AM, El-Kholy AA. Elhelw HA, et al. Clin Exp Vaccine Res. 2022 Jan;11(1):30-42. doi: 10.7774/cevr.2022.11.1.30. Epub 2022 Jan 31. Clin Exp Vaccine Res. 2022. PMID: 35223663 Free PMC article.

117

Expression of full and fragment-B of diphtheria toxin genes in Escherichia coli for generating of recombinant diphtheria vaccines.

Abulmagd S, Khattab AEA, Zedan H. Abulmagd S, et al. Clin Exp Vaccine Res. 2022 Jan;11(1):12-29. doi: 10.7774/cevr.2022.11.1.12. Epub 2022 Jan 31. Clin Exp Vaccine Res. 2022. PMID: 35223662 Free PMC article.

118

Comparison and efficacy of two different sheep pox vaccines prepared from the Bakırköy strain against lumpy skin disease in cattle.

Uzar S, Sarac F, Gulyaz V, Enul H, Yılmaz H, Turan N. Uzar S, et al. Clin Exp Vaccine Res. 2022 Jan;11(1):1-11. doi: 10.7774/cevr.2022.11.1.1. Epub 2022 Jan 31. Clin Exp Vaccine Res. 2022. PMID: 35223661 Free PMC article.

119

Are the COVID-19's vaccines efficient on the most dangerous variant of SARS-CoV-2?

Davoodi P, Hashemi A. Davoodi P, et al. Clin Exp Vaccine Res. 2021 Sep;10(3):301-303. doi: 10.7774/cevr.2021.10.3.301. Epub 2021 Sep 30. Clin Exp Vaccine Res. 2021. PMID: 34703817 Free PMC article. No abstract available.

120

Acute urticarial rash after COVID-19 vaccination containing Polysorbate 80.

Burlando M, Herzum A, Cozzani E, Parodi A. Burlando M, et al. Clin Exp Vaccine Res. 2021 Sep;10(3):298-300. doi: 10.7774/cevr.2021.10.3.298. Epub 2021 Sep 30. Clin Exp Vaccine Res. 2021. PMID: 34703816 Free PMC article.

121

A case of acute encephalopathy and non-ST segment elevation myocardial infarction following mRNA-1273 vaccination: possible adverse effect?

Barsha SY, Akiful Haque MM, Rashid MU, Rahman ML, Hossain MA, Zaman S, Bhuiyan E, Sultana R, Hossian M, Nabi MH, Hawlader MDH. Barsha SY, et al. Clin Exp Vaccine Res. 2021 Sep;10(3):293-297. doi: 10.7774/cevr.2021.10.3.293. Epub 2021 Sep 30. Clin Exp Vaccine Res. 2021. PMID: 34703815 Free PMC article.

122

Shingles and mRNA COVID-19 vaccine.

Mungmunpuntipantip R, Wiwanitkit V. Mungmunpuntipantip R, et al. Clin Exp Vaccine Res. 2021 Sep;10(3):292. doi: 10.7774/cevr.2021.10.3.292. Epub 2021 Sep 30. Clin Exp Vaccine Res. 2021. PMID: 34703814 Free PMC article. No abstract available.

123

Challenges managing COVID vaccine-induced immune thrombotic thrombocytopenia in low-middle income countries.

Ramírez C, Hernández RJS, Durón RM. Ramírez C, et al. Clin Exp Vaccine Res. 2021 Sep;10(3):290-291. doi: 10.7774/cevr.2021.10.3.290. Epub 2021 Sep 30. Clin Exp Vaccine Res. 2021. PMID: 34703813 Free PMC article. No abstract available.

124

Reactogenicity after the first and second doses of BNT162b2 mRNA coronavirus disease vaccine: a single-center study.

Kang YM, Lim J, Choe KW, Lee KD, Jo DH, Kim MJ, Kim JM, Kim KN. Kang YM, et al. Clin Exp Vaccine Res. 2021 Sep;10(3):282-289. doi: 10.7774/cevr.2021.10.3.282. Epub 2021 Sep 30. Clin Exp Vaccine Res. 2021. PMID: 34703812 Free PMC article.

125

Severity of COVID-19 in bacillus Calmette-Guérin vaccinated population.

Khanum I, Kumar L, Awan S, Jamil B. Khanum I, et al. Clin Exp Vaccine Res. 2021 Sep;10(3):276-281. doi: 10.7774/cevr.2021.10.3.276. Epub 2021 Sep 30. Clin Exp Vaccine Res. 2021. PMID: 34703811 Free PMC article.

126

Post-vaccination COVID-19 deaths: a review of available evidence and recommendations for the global population.

Lamptey E. Lamptey E. Clin Exp Vaccine Res. 2021 Sep;10(3):264-275. doi: 10.7774/cevr.2021.10.3.264. Epub 2021 Sep 30. Clin Exp Vaccine Res. 2021. PMID: 34703810 Free PMC article. Review.

127

The effect of apolipoprotein A-I and perfluorocarbon emulsion on the production of specific antibodies in mice.

Zhalimov V, Gritsyna Y, Morenkov O. Zhalimov V, et al. Clin Exp Vaccine Res. 2021 Sep;10(3):259-263. doi: 10.7774/cevr.2021.10.3.259. Epub 2021 Sep 30. Clin Exp Vaccine Res. 2021. PMID: 34703809 Free PMC article.

128

Evaluation of the antigenic stability of influenza virus like particles after exposure to acidic or basic pH.

Kim SH, Park YC, Song JM. Kim SH, et al. Clin Exp Vaccine Res. 2021 Sep;10(3):252-258. doi: 10.7774/cevr.2021.10.3.252. Epub 2021 Sep 30. Clin Exp Vaccine Res. 2021. PMID: 34703808 Free PMC article.

129

Transient expression of fusion and hemagglutinin-neuraminidase epitopes of Newcastle disease virus in maize as a potent candidate vaccine.

Shahriari AG, Niazi A, Habibi-Pirkoohi M. Shahriari AG, et al. Clin Exp Vaccine Res. 2021 Sep;10(3):245-251. doi: 10.7774/cevr.2021.10.3.245. Epub 2021 Sep 30. Clin Exp Vaccine Res. 2021. PMID: 34703807 Free PMC article.

130

Vaccine usage and wastage in a designated Yellow Fever Vaccination Centre in North India.

Dkhar SA, Quansar R, Haq I, Khan SMS. Dkhar SA, et al. Clin Exp Vaccine Res. 2021 Sep;10(3):240-244. doi: 10.7774/cevr.2021.10.3.240. Epub 2021 Sep 30. Clin Exp Vaccine Res. 2021. PMID: 34703806 Free PMC article.

131

Staphylococcus aureus derived hyaluronic acid and bacillus Calmette-Guérin purified proteins as immune enhancers to rabies vaccine and related immuno-histopathological alterations.

Shebl RI, Amer ME, Abuamara TMM, Matar ER, Ahmed HF, Gomah TA, El Moselhy LE, Abu-Elghait M, Mohamed AF. Shebl RI, et al. Clin Exp Vaccine Res. 2021 Sep;10(3):229-239. doi: 10.7774/cevr.2021.10.3.229. Epub 2021 Sep 30. Clin Exp Vaccine Res. 2021. PMID: 34703805 Free PMC article.

132

Oral immunization of rat with chromosomal expression LipL32 in attenuated Salmonella vaccine induces immune respond against pathogenic Leptospira.

Samakchan N, Thinwang P, Boonyom R. Samakchan N, et al. Clin Exp Vaccine Res. 2021 Sep;10(3):217-228. doi: 10.7774/cevr.2021.10.3.217. Epub 2021 Sep 30. Clin Exp Vaccine Res. 2021. PMID: 34703804 Free PMC article.

133

Adverse events following pediatric immunization in an Indian city.

Paramkusham V, Palakurthy P, Gurram NS, Talla V, Vishwas HN, Jupally VR, Pattnaik S. Paramkusham V, et al. Clin Exp Vaccine Res. 2021 Sep;10(3):211-216. doi: 10.7774/cevr.2021.10.3.211. Epub 2021 Sep 30. Clin Exp Vaccine Res. 2021. PMID: 34703803 Free PMC article.

134

Parenteral, non-live rotavirus vaccine: recent history and future perspective.

Song JM. Song JM. Clin Exp Vaccine Res. 2021 Sep;10(3):203-210. doi: 10.7774/cevr.2021.10.3.203. Epub 2021 Sep 30. Clin Exp Vaccine Res. 2021. PMID: 34703802 Free PMC article. Review.

135

A rare case of shingles after COVID-19 vaccine: is it a possible adverse effect?

Aksu SB, Öztürk GZ. Aksu SB, et al. Clin Exp Vaccine Res. 2021 May;10(2):198-201. doi: 10.7774/cevr.2021.10.2.198. Epub 2021 May 31. Clin Exp Vaccine Res. 2021. PMID: 34222134 Free PMC article.

136

Acute myocarditis associated with anti-COVID-19 vaccination.

Nevet A. Nevet A. Clin Exp Vaccine Res. 2021 May;10(2):196-197. doi: 10.7774/cevr.2021.10.2.196. Epub 2021 May 31. Clin Exp Vaccine Res. 2021. PMID: 34222133 Free PMC article.

137

A possible protective role for Bacillus Calmette-Guérin therapy in urinary bladder cancer in the era of COVID-19: a brief report.

Ohadian Moghadam S, Abbasi B, Nowroozi A, Amini E, Nowroozi MR, Momeni SA, Niroomand H. Ohadian Moghadam S, et al. Clin Exp Vaccine Res. 2021 May;10(2):191-195. doi: 10.7774/cevr.2021.10.2.191. Epub 2021 May 31. Clin Exp Vaccine Res. 2021. PMID: 34222132 Free PMC article.

138

A nationwide survey of the potential acceptance and determinants of COVID-19 vaccines in Ghana.

Lamptey E, Serwaa D, Appiah AB. Lamptey E, et al. Clin Exp Vaccine Res. 2021 May;10(2):183-190. doi: 10.7774/cevr.2021.10.2.183. Epub 2021 May 31. Clin Exp Vaccine Res. 2021. PMID: 34222131 Free PMC article.

139

Determinants of the willingness of the general population to get vaccinated against COVID-19 in a developing country.

Al-Mistarehi AH, Kheirallah KA, Yassin A, Alomari S, Aledrisi MK, Bani Ata EM, Hammad NH, Khanfar AN, Ibnian AM, Khassawneh BY. Al-Mistarehi AH, et al. Clin Exp Vaccine Res. 2021 May;10(2):171-182. doi: 10.7774/cevr.2021.10.2.171. Epub 2021 May 31. Clin Exp Vaccine Res. 2021. PMID: 34222130 Free PMC article.

140

Inside the story about the research and development of COVID-19 vaccines.

Patel SP, Patel GS, Suthar JV. Patel SP, et al. Clin Exp Vaccine Res. 2021 May;10(2):154-170. doi: 10.7774/cevr.2021.10.2.154. Epub 2021 May 31. Clin Exp Vaccine Res. 2021. PMID: 34222129 Free PMC article. Review.

141

Fight against COVID-19 with mRNA vaccines and interaction with Dermal fillers.

Ghasemi S, Dashti M. Ghasemi S, et al. Clin Exp Vaccine Res. 2021 May;10(2):151-153. doi: 10.7774/cevr.2021.10.2.151. Epub 2021 May 31. Clin Exp Vaccine Res. 2021. PMID: 34222128 Free PMC article.

142

Vaccines are not one size fits all, just like medications: rotavirus vaccine study.

Varre JV. Varre JV. Clin Exp Vaccine Res. 2021 May;10(2):148-150. doi: 10.7774/cevr.2021.10.2.148. Epub 2021 May 31. Clin Exp Vaccine Res. 2021. PMID: 34222127 Free PMC article.

143

Immunogenicity of an inactivated rabies vaccine for animals derived from the recombinant ERAGS strain.

Yang DK, Kim HH, Park YR, Yoo JY, Park Y, An S, Hyun BH. Yang DK, et al. Clin Exp Vaccine Res. 2021 May;10(2):141-147. doi: 10.7774/cevr.2021.10.2.141. Epub 2021 May 31. Clin Exp Vaccine Res. 2021. PMID: 34222126 Free PMC article.

144

Outer membrane proteins of Salmonella typhimurium as an adjuvant in rabies vaccine.

Negm II, Ragab YM, Mohamed AF. Negm II, et al. Clin Exp Vaccine Res. 2021 May;10(2):132-140. doi: 10.7774/cevr.2021.10.2.132. Epub 2021 May 31. Clin Exp Vaccine Res. 2021. PMID: 34222125 Free PMC article.

145

Novel antigen panel for modern broad-spectrum recombinant rotavirus A vaccine.

Kondakova OA, Ivanov PA, Baranov OA, Ryabchevskaya EM, Arkhipenko MV, Skurat EV, Evtushenko EA, Nikitin NA, Karpova OV. Kondakova OA, et al. Clin Exp Vaccine Res. 2021 May;10(2):123-131. doi: 10.7774/cevr.2021.10.2.123. Epub 2021 May 31. Clin Exp Vaccine Res. 2021. PMID: 34222124 Free PMC article.

146

Immunogenicity of antigens from outer membrane vesicles of Neisseria meningitidis associated with bilayer fragment of dioctadecyldimethylammonium in Swiss adult mice.

Rinaldi FM, Gaspar EB, Brito LT, Gaspari E. Rinaldi FM, et al. Clin Exp Vaccine Res. 2021 May;10(2):106-122. doi: 10.7774/cevr.2021.10.2.106. Epub 2021 May 31. Clin Exp Vaccine Res. 2021. PMID: 34222123 Free PMC article.

147

Comparison of regulatory framework of clinical trial with genetically modified organism-containing vaccines in the Europe, Australia, and Switzerland.

Jose J, Pai S. Jose J, et al. Clin Exp Vaccine Res. 2021 May;10(2):93-105. doi: 10.7774/cevr.2021.10.2.93. Epub 2021 May 31. Clin Exp Vaccine Res. 2021. PMID: 34222122 Free PMC article. Review.

148

Impact of vaccination on carriage of and infection by antibiotic-resistant bacteria: a systematic review and meta-analysis.

Wang LM, Cravo Oliveira Hashiguchi T, Cecchini M. Wang LM, et al. Clin Exp Vaccine Res. 2021 May;10(2):81-92. doi: 10.7774/cevr.2021.10.2.81. Epub 2021 May 31. Clin Exp Vaccine Res. 2021. PMID: 34222121 Free PMC article. Review.

149

Pan-vasculitis and fulminant hepatitis following routine vaccination at the age of 4 months.

Awad MH, El-Hawary A, Sawah G, Nasef N. Awad MH, et al. Clin Exp Vaccine Res. 2021 Jan;10(1):78-80. doi: 10.7774/cevr.2021.10.1.78. Epub 2021 Jan 31. Clin Exp Vaccine Res. 2021. PMID: 33628757 Free PMC article.

150

Immunoinformatic analysis of immunogenic B- and T-cell epitopes of MIC4 protein to designing a vaccine candidate against Toxoplasma gondii through an in-silico approach.

Ghaffari AD, Dalimi A, Ghaffarifar F, Pirestani M, Majidiani H. Ghaffari AD, et al. Clin Exp Vaccine Res. 2021 Jan;10(1):59-77. doi: 10.7774/cevr.2021.10.1.59. Epub 2021 Jan 31. Clin Exp Vaccine Res. 2021. PMID: 33628756 Free PMC article.

151

Efficacy of physical and chemical treatments on the inactivation of bovine leukosis virus present in milk.

Sandoval-Monzón RS, Arévalo-Rodriguez ICK, Carrillo-Torres AA, Ruiz-García LF. Sandoval-Monzón RS, et al. Clin Exp Vaccine Res. 2021 Jan;10(1):52-58. doi: 10.7774/cevr.2021.10.1.52. Epub 2021 Jan 31. Clin Exp Vaccine Res. 2021. PMID: 33628755 Free PMC article.

152

A comparison of post vaccination hepatitis B surface antibody level on the large and appropriate for gestational age infants.

Esteghamati A, Sayyahfar S, Ghaemi H, Joulani M, Moradi Y, Talebi A. Esteghamati A, et al. Clin Exp Vaccine Res. 2021 Jan;10(1):47-51. doi: 10.7774/cevr.2021.10.1.47. Epub 2021 Jan 31. Clin Exp Vaccine Res. 2021. PMID: 33628754 Free PMC article.

153

Adverse events associated with Measles and Rubella vaccination campaign 2019 in India.

Sharma R, Gaur A. Sharma R, et al. Clin Exp Vaccine Res. 2021 Jan;10(1):44-46. doi: 10.7774/cevr.2021.10.1.44. Epub 2021 Jan 31. Clin Exp Vaccine Res. 2021. PMID: 33628753 Free PMC article.

154

Immunogenicity of glycine nanoparticles containing a chimeric antigen as Brucella vaccine candidate.

Karevan G, Ahmadi K, Taheri RA, Fasihi-Ramandi M. Karevan G, et al. Clin Exp Vaccine Res. 2021 Jan;10(1):35-43. doi: 10.7774/cevr.2021.10.1.35. Epub 2021 Jan 31. Clin Exp Vaccine Res. 2021. PMID: 33628752 Free PMC article.

155

Biological properties the novel application of N-trimethyl chitosan nanospheres as a stabilizer and preservative in tetanus vaccine.

Ghalavand M, Saadati M, Salimian J, Abbasi E, Hosseinzadeh G, Gouvarchin Ghaleh HE, Ahmadi A. Ghalavand M, et al. Clin Exp Vaccine Res. 2021 Jan;10(1):24-34. doi: 10.7774/cevr.2021.10.1.24. Epub 2021 Jan 31. Clin Exp Vaccine Res. 2021. PMID: 33628751 Free PMC article.

156

Current updates and research on plant-based vaccines for coronavirus disease 2019.

Uthaya Kumar A, Kadiresen K, Gan WC, Ling APK. Uthaya Kumar A, et al. Clin Exp Vaccine Res. 2021 Jan;10(1):13-23. doi: 10.7774/cevr.2021.10.1.13. Epub 2021 Jan 31. Clin Exp Vaccine Res. 2021. PMID: 33628750 Free PMC article. Review.

157

A review on the advancements in the development of vaccines to combat coronavirus disease 2019.

Onyeaka H, Al-Sharify ZT, Ghadhban MY, Al-Najjar SZ. Onyeaka H, et al. Clin Exp Vaccine Res. 2021 Jan;10(1):6-12. doi: 10.7774/cevr.2021.10.1.6. Epub 2021 Jan 31. Clin Exp Vaccine Res. 2021. PMID: 33628749 Free PMC article. Review.

158

Polyvaccine: joining the links in the cascade of type 1 diabetes.

Desai S, Bhonde RR, Parekh SS. Desai S, et al. Clin Exp Vaccine Res. 2021 Jan;10(1):1-5. doi: 10.7774/cevr.2021.10.1.1. Epub 2021 Jan 31. Clin Exp Vaccine Res. 2021. PMID: 33628748 Free PMC article. Review.

159

Is the impact of childhood vaccines on coronavirus disease 2019, which is moderate in pediatric patients, possible?

Bozkurt HB. Bozkurt HB. Clin Exp Vaccine Res. 2020 Jul;9(2):183-184. doi: 10.7774/cevr.2020.9.2.183. Epub 2020 Jul 31. Clin Exp Vaccine Res. 2020. PMID: 32864377 Free PMC article. No abstract available.

160

Current national policies for infant universal bacille Calmette-Guérin vaccination were associated with lower mortality from coronavirus disease 2019.

Ebina-Shibuya R, Horita N, Namkoong H, Kaneko T. Ebina-Shibuya R, et al. Clin Exp Vaccine Res. 2020 Jul;9(2):179-182. doi: 10.7774/cevr.2020.9.2.179. Epub 2020 Jul 31. Clin Exp Vaccine Res. 2020. PMID: 32864376 Free PMC article.

161

Potential use of 3-(trimethoxysilyl)propyldimethyl octadecyl ammonium chloride as an antimicrobial and antiviral agent for the disinfection of personal protective equipment.

Kim Y, Youn H, Kim J, Lee D, Go S, Park JE, Lee S, Noh J, Nahm SS. Kim Y, et al. Clin Exp Vaccine Res. 2020 Jul;9(2):174-178. doi: 10.7774/cevr.2020.9.2.174. Epub 2020 Jul 31. Clin Exp Vaccine Res. 2020. PMID: 32864375 Free PMC article.

162

Coronavirus epitope prediction from highly conserved region of spike protein.

Yurina V. Yurina V. Clin Exp Vaccine Res. 2020 Jul;9(2):169-173. doi: 10.7774/cevr.2020.9.2.169. Epub 2020 Jul 31. Clin Exp Vaccine Res. 2020. PMID: 32864374 Free PMC article.

163

An edible vaccine development for coronavirus disease 2019: the concept.

Sohrab SS. Sohrab SS. Clin Exp Vaccine Res. 2020 Jul;9(2):164-168. doi: 10.7774/cevr.2020.9.2.164. Epub 2020 Jul 31. Clin Exp Vaccine Res. 2020. PMID: 32864373 Free PMC article. Review.

164

Gemini lipopeptides as vaccine adjuvants: a new role for these versatile carriers.

Grippo LD, Reidel IG, García MI, Streu A, Müller DM, Veaute CM. Grippo LD, et al. Clin Exp Vaccine Res. 2020 Jul;9(2):159-163. doi: 10.7774/cevr.2020.9.2.159. Epub 2020 Jul 31. Clin Exp Vaccine Res. 2020. PMID: 32864372 Free PMC article.

165

In-depth computational analysis of calcium-dependent protein kinase 3 of Toxoplasma gondii provides promising targets for vaccination.

Majidiani H, Soltani S, Ghaffari AD, Sabaghan M, Taghipour A, Foroutan M. Majidiani H, et al. Clin Exp Vaccine Res. 2020 Jul;9(2):146-158. doi: 10.7774/cevr.2020.9.2.146. Epub 2020 Jul 31. Clin Exp Vaccine Res. 2020. PMID: 32864371 Free PMC article.

166

Investigation of adverse events following bacille Calmette-Guérin immunization using immunization safety surveillance system in Korea Centers for Disease Control and Prevention.

Roh EJ, Lee YK, Lee MH, Kim MK, Kim TE, Lee SG, Chung EH. Roh EJ, et al. Clin Exp Vaccine Res. 2020 Jul;9(2):133-145. doi: 10.7774/cevr.2020.9.2.133. Epub 2020 Jul 31. Clin Exp Vaccine Res. 2020. PMID: 32864370 Free PMC article.

167

Influence of temperature on the antigenic changes of virus-like particles.

Shin JI, Park YC, Song JM. Shin JI, et al. Clin Exp Vaccine Res. 2020 Jul;9(2):126-132. doi: 10.7774/cevr.2020.9.2.126. Epub 2020 Jul 31. Clin Exp Vaccine Res. 2020. PMID: 32864369 Free PMC article.

168

Preparation and efficacy of freeze-dried inactivated vaccine against bovine viral diarrhea virus genotypes 1 and 2, bovine herpes virus type 1.1, bovine parainfluenza-3 virus, and bovine respiratory syncytial virus.

Abd El Fadeel MR, El-Dakhly AT, Allam AM, Farag TK, El-Kholy AA. Abd El Fadeel MR, et al. Clin Exp Vaccine Res. 2020 Jul;9(2):119-125. doi: 10.7774/cevr.2020.9.2.119. Epub 2020 Jul 31. Clin Exp Vaccine Res. 2020. PMID: 32864368 Free PMC article.

169

Bluetongue virus viral protein 7 stability in the presence of glycerol and sodium chloride.

Russell BL, Gildenhuys S. Russell BL, et al. Clin Exp Vaccine Res. 2020 Jul;9(2):108-118. doi: 10.7774/cevr.2020.9.2.108. Epub 2020 Jul 31. Clin Exp Vaccine Res. 2020. PMID: 32864367 Free PMC article.

170

Genotype-specific neutralizing antibody titers against Japanese encephalitis virus genotypes 1 and 3 in horses immunized with a genotype 3 vaccine.

Kim HH, Yang DK, Ji M, Lee SK, Hyun BH. Kim HH, et al. Clin Exp Vaccine Res. 2020 Jul;9(2):102-107. doi: 10.7774/cevr.2020.9.2.102. Epub 2020 Jul 31. Clin Exp Vaccine Res. 2020. PMID: 32864366 Free PMC article.

171

Determination of non-structural protein level for Turkey foot-and-mouth disease vaccine antigens during in-process.

Sareyyüpoğlu B, Çokçalışkan C, Çoskuner A, Gülyaz V. Sareyyüpoğlu B, et al. Clin Exp Vaccine Res. 2020 Jul;9(2):97-101. doi: 10.7774/cevr.2020.9.2.97. Epub 2020 Jul 31. Clin Exp Vaccine Res. 2020. PMID: 32864365 Free PMC article.

172

Antigenic properties of dense granule antigen 12 protein using bioinformatics tools in order to improve vaccine design against Toxoplasma gondii.

Ghaffari AD, Dalimi A, Ghaffarifar F, Pirestani M. Ghaffari AD, et al. Clin Exp Vaccine Res. 2020 Jul;9(2):81-96. doi: 10.7774/cevr.2020.9.2.81. Epub 2020 Jul 31. Clin Exp Vaccine Res. 2020. PMID: 32864364 Free PMC article.

173

Autolysin (lytA) recombinant protein: a potential target for developing vaccines against pneumococcal infections.

Afshar D, Rafiee F, Kheirandish M, Ohadian Moghadam S, Azarsa M. Afshar D, et al. Clin Exp Vaccine Res. 2020 Jul;9(2):76-80. doi: 10.7774/cevr.2020.9.2.76. Epub 2020 Jul 31. Clin Exp Vaccine Res. 2020. PMID: 32864363 Free PMC article.

174

Vaccines in the United States: a systematic review on history of evolution, regulations, licensing, and future challenges.

Sathyanarayana SD, Fernandes SD, Castelino LJ, Vadakkepushpakath AN, Shriram RG. Sathyanarayana SD, et al. Clin Exp Vaccine Res. 2020 Jul;9(2):69-75. doi: 10.7774/cevr.2020.9.2.69. Epub 2020 Jul 31. Clin Exp Vaccine Res. 2020. PMID: 32864362 Free PMC article. Review.

175

Seroprevalence of mumps in healthcare workers in South Korea.

Kim SK, Jung J, Kwak SH, Hong MJ, Kim SH. Kim SK, et al. Clin Exp Vaccine Res. 2020 Jan;9(1):64-67. doi: 10.7774/cevr.2020.9.1.64. Epub 2020 Jan 31. Clin Exp Vaccine Res. 2020. PMID: 32095442 Free PMC article.

176

Comparison of antigenic mutation during egg and cell passage cultivation of H3N2 influenza virus.

Park YW, Kim YH, Jung HU, Jeong OS, Hong EJ, Kim H, Lee JI. Park YW, et al. Clin Exp Vaccine Res. 2020 Jan;9(1):56-63. doi: 10.7774/cevr.2020.9.1.56. Epub 2020 Jan 31. Clin Exp Vaccine Res. 2020. PMID: 32095441 Free PMC article.

177

Suspension culture of Vero cells for the production of adenovirus type 5.

Lee DK, Park J, Seo DW. Lee DK, et al. Clin Exp Vaccine Res. 2020 Jan;9(1):48-55. doi: 10.7774/cevr.2020.9.1.48. Epub 2020 Jan 31. Clin Exp Vaccine Res. 2020. PMID: 32095440 Free PMC article.

178

Immunogenicity of a new, inactivated canine adenovirus type 2 vaccine for dogs.

Yang DK, Kim HH, Yoo JY, Ji M, Han BH, Oh S, Hyun BH. Yang DK, et al. Clin Exp Vaccine Res. 2020 Jan;9(1):40-47. doi: 10.7774/cevr.2020.9.1.40. Epub 2020 Jan 31. Clin Exp Vaccine Res. 2020. PMID: 32095439 Free PMC article.

179

The potential efficacy of the E2-subunit vaccine to protect pigs against different genotypes of classical swine fever virus circulating in Vietnam.

Tran HTT, Truong DA, Ly VD, Vu HT, Hoang TV, Nguyen CT, Chu NT, Nguyen VT, Nguyen DT, Miyazawa K, Kokuho T, Dang HV. Tran HTT, et al. Clin Exp Vaccine Res. 2020 Jan;9(1):26-39. doi: 10.7774/cevr.2020.9.1.26. Epub 2020 Jan 31. Clin Exp Vaccine Res. 2020. PMID: 32095438 Free PMC article.

180

Reverse vaccinology approach for the identification and characterization of outer membrane proteins of Shigella flexneri as potential cellular- and antibody-dependent vaccine candidates.

Leow CY, Kazi A, Hisyam Ismail CMK, Chuah C, Lim BH, Leow CH, Banga Singh KK. Leow CY, et al. Clin Exp Vaccine Res. 2020 Jan;9(1):15-25. doi: 10.7774/cevr.2020.9.1.15. Epub 2020 Jan 31. Clin Exp Vaccine Res. 2020. PMID: 32095437 Free PMC article.

181

Cold chain time- and temperature-controlled transport of vaccines: a simulated experimental study.

Ng CZ, Lean YL, Yeoh SF, Lean QY, Lee KS, Suleiman AK, Liew KB, Kassab YW, Al-Worafi YM, Ming LC. Ng CZ, et al. Clin Exp Vaccine Res. 2020 Jan;9(1):8-14. doi: 10.7774/cevr.2020.9.1.8. Epub 2020 Jan 31. Clin Exp Vaccine Res. 2020. PMID: 32095436 Free PMC article.

182

Hepatitis B vaccination and immunotherapies: an update.

Stasi C, Silvestri C, Voller F. Stasi C, et al. Clin Exp Vaccine Res. 2020 Jan;9(1):1-7. doi: 10.7774/cevr.2020.9.1.1. Epub 2020 Jan 31. Clin Exp Vaccine Res. 2020. PMID: 32095435 Free PMC article. Review.

183

Plant factory: new resource for the productivity and diversity of human and veterinary vaccines.

Shim BS, Hong KJ, Maharjan PM, Choe S. Shim BS, et al. Clin Exp Vaccine Res. 2019 Jul;8(2):136-139. doi: 10.7774/cevr.2019.8.2.136. Epub 2019 Jul 31. Clin Exp Vaccine Res. 2019. PMID: 31406696 Free PMC article.

184

Rabies immune status of raccoon dogs residing in areas where rabies bait vaccine has been distributed.

Yang DK, Kim HH, Lee EJ, Yoo JY, Kim JT, Ahn S. Yang DK, et al. Clin Exp Vaccine Res. 2019 Jul;8(2):132-135. doi: 10.7774/cevr.2019.8.2.132. Epub 2019 Jul 31. Clin Exp Vaccine Res. 2019. PMID: 31406695 Free PMC article.

185

Transient expression of hemagglutinin antigen from canine influenza virus H3N2 in Nicotiana benthamiana and Lactuca sativa.

Maharjan PM, Choe S. Maharjan PM, et al. Clin Exp Vaccine Res. 2019 Jul;8(2):124-131. doi: 10.7774/cevr.2019.8.2.124. Epub 2019 Jul 31. Clin Exp Vaccine Res. 2019. PMID: 31406694 Free PMC article.

186

A clinico-epidemiological multicenter study of herpes zoster in immunocompetent and immunocompromised hospitalized children.

Hwang JH, Kim KH, Han SB, Kim HH, Kim JH, Lee SY, Choi UY, Kang JH. Hwang JH, et al. Clin Exp Vaccine Res. 2019 Jul;8(2):116-123. doi: 10.7774/cevr.2019.8.2.116. Epub 2019 Jul 31. Clin Exp Vaccine Res. 2019. PMID: 31406693 Free PMC article.

187

A meningococcal B vaccine induces cross-protection against gonorrhea.

Azze RFO. Azze RFO. Clin Exp Vaccine Res. 2019 Jul;8(2):110-115. doi: 10.7774/cevr.2019.8.2.110. Epub 2019 Jul 31. Clin Exp Vaccine Res. 2019. PMID: 31406692 Free PMC article.

188

Effect of simultaneous administration of foot-and-mouth disease (FMD) and anthrax vaccines on antibody response to FMD in sheep.

Çokçalışkan C, Tuncer Göktuna P, Türkoğlu T, Uzunlu E, Gündüzalp C, Uzun EA, Sareyyüpoğlu B, Kürkçü A, Gülyaz V. Çokçalışkan C, et al. Clin Exp Vaccine Res. 2019 Jul;8(2):103-109. doi: 10.7774/cevr.2019.8.2.103. Epub 2019 Jul 31. Clin Exp Vaccine Res. 2019. PMID: 31406691 Free PMC article.

189

One-year antibody persistence and safety of a 4-dose schedule of MenACWY-CRM in healthy infants from South Korea.

Lee HJ, Jo DS, Kim YK, Lee H, Kim KH, Lee D, Curina C, Costantini M, Barbi S, Miao Y, Pellegrini M. Lee HJ, et al. Clin Exp Vaccine Res. 2019 Jul;8(2):94-102. doi: 10.7774/cevr.2019.8.2.94. Epub 2019 Jul 31. Clin Exp Vaccine Res. 2019. PMID: 31406690 Free PMC article.

190

Non-invasive molecular imaging of immune cell dynamics for vaccine research.

Youn H, Hong KJ. Youn H, et al. Clin Exp Vaccine Res. 2019 Jul;8(2):89-93. doi: 10.7774/cevr.2019.8.2.89. Epub 2019 Jul 31. Clin Exp Vaccine Res. 2019. PMID: 31406689 Free PMC article. Review.

191

Absence of neutralizing activity in serum 1 year after successful treatment with antivirals and recovery from MERS in South Korea.

Choi JY, Oh JO, Ahn JY, Choi H, Kim JH, Seong H, Jeong SJ, Ku NS, Yeom JS, Choi JP. Choi JY, et al. Clin Exp Vaccine Res. 2019 Jan;8(1):86-88. doi: 10.7774/cevr.2019.8.1.86. Epub 2019 Jan 31. Clin Exp Vaccine Res. 2019. PMID: 30775355 Free PMC article.

192

Patterns and trends of malaria in 25 risk districts of Nepal from 2001 to 2017.

Gautam N, Kakchapati S, Shrestha S, Wanishsakpong W. Gautam N, et al. Clin Exp Vaccine Res. 2019 Jan;8(1):77-85. doi: 10.7774/cevr.2019.8.1.77. Epub 2019 Jan 31. Clin Exp Vaccine Res. 2019. PMID: 30775354 Free PMC article.

193

Development of a HA1-specific enzyme-linked immunosorbent assay against pandemic influenza virus A H1N1.

Shim DH, Kim MJ, Cha HR, Park ES, Kim AR, Park JH, Park HC, Song D, Lee JM. Shim DH, et al. Clin Exp Vaccine Res. 2019 Jan;8(1):70-76. doi: 10.7774/cevr.2019.8.1.70. Epub 2019 Jan 31. Clin Exp Vaccine Res. 2019. PMID: 30775353 Free PMC article.

194

Enzyme-linked immunosorbent assay for detecting anti-pertussis toxin antibody in mouse.

Choi GS, Huh DH, Han SB, Ahn DH, Kang KR, Kim JA, Choi BM, Kim HR, Kang JH. Choi GS, et al. Clin Exp Vaccine Res. 2019 Jan;8(1):64-69. doi: 10.7774/cevr.2019.8.1.64. Epub 2019 Jan 31. Clin Exp Vaccine Res. 2019. PMID: 30775352 Free PMC article.

195

Nucleoprotein vaccine induces cross-protective cytotoxic T lymphocytes against both lineages of influenza B virus.

Lee SY, Kang JO, Chang J. Lee SY, et al. Clin Exp Vaccine Res. 2019 Jan;8(1):54-63. doi: 10.7774/cevr.2019.8.1.54. Epub 2019 Jan 31. Clin Exp Vaccine Res. 2019. PMID: 30775351 Free PMC article.

196

Vaccine containing G protein fragment and recombinant baculovirus expressing M2 protein induces protective immunity to respiratory syncytial virus.

Jo YM, Kim J, Chang J. Jo YM, et al. Clin Exp Vaccine Res. 2019 Jan;8(1):43-53. doi: 10.7774/cevr.2019.8.1.43. Epub 2019 Jan 31. Clin Exp Vaccine Res. 2019. PMID: 30775350 Free PMC article.

197

Development and implementation of standardized method for detecting immunogenicity of acellular pertussis vaccines in Korea.

Park C, Huh DH, Han SB, Choi GS, Kang KR, Kim JA, Kang JH. Park C, et al. Clin Exp Vaccine Res. 2019 Jan;8(1):35-42. doi: 10.7774/cevr.2019.8.1.35. Epub 2019 Jan 31. Clin Exp Vaccine Res. 2019. PMID: 30775349 Free PMC article.

198

Expression and serological application of recombinant epitope-repeat protein carrying an immunodominant epitope of Newcastle disease virus nucleoprotein.

Gaikwad SS, Lee HJ, Kim JY, Choi KS. Gaikwad SS, et al. Clin Exp Vaccine Res. 2019 Jan;8(1):27-34. doi: 10.7774/cevr.2019.8.1.27. Epub 2019 Jan 31. Clin Exp Vaccine Res. 2019. PMID: 30775348 Free PMC article.

199

Rhoptry antigens as Toxoplasma gondii vaccine target.

Foroutan M, Ghaffarifar F, Sharifi Z, Dalimi A, Jorjani O. Foroutan M, et al. Clin Exp Vaccine Res. 2019 Jan;8(1):4-26. doi: 10.7774/cevr.2019.8.1.4. Epub 2019 Jan 31. Clin Exp Vaccine Res. 2019. PMID: 30775347 Free PMC article. Review.

200

A national project to build a business support facility for plant-derived vaccine.

Choi BH, Kim DY. Choi BH, et al. Clin Exp Vaccine Res. 2019 Jan;8(1):1-3. doi: 10.7774/cevr.2019.8.1.1. Epub 2019 Jan 31. Clin Exp Vaccine Res. 2019. PMID: 30775346 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

354 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

354 results

Results by year